author-photo

Dianna Riall

University of Texas MD Anderson Cancer Center

2

Papers

61

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Abstract B24: Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

2020 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

2019 Breast Cancer Research
Show All
- Source
- Cite
- Save
Citations (61)